 |
|
|
| |
Evaluating the relationship between inflammation biomarker interleukin-6
(IL-6) levels and residual, low-Level viraemia in HIV-1 suppressed
participants in the TANGO study at week 96 (WK96)
|
| |
| |
18th EACS Oct 27-30 London, UK
R. Wang1, E. Bernal-Morell2, C. Brinson3, J. Sanz Moreno4, S. Scholten5, R. Moore6, J. Wright7, W. Chen1, N. George7, M. Ait-Khaled8, P. Leone1, B. Wynne1, J. van Wyk8, J. van Lunzen8, M. Underwood1
1ViiV Healthcare, Research Triangle Park, United States, 2Hospital General Universitario Reina Sofia, Murcia, Spain, 3Central Texas Clinical Research, Austin, United States, 4Hospital Principe de Asturias, Alcalá de Henares, Spain, 5Praxis Hohenstaufenring, Cologne, Germany, 6Northside Clinic, Fitzroy North, Australia, 7GlaxoSmithKline, Brentford, United Kingdom, 8ViiV Healthcare, Brentford, United Kingdom
|
| |
|
|
|
|
|
